# A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

> **NCT00621218** · PHASE2 · COMPLETED · sponsor: **Coria Laboratories, Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** tretinoin gel 0.05%
- **DRUG:** vehicle

## Key facts

- **NCT ID:** NCT00621218
- **Lead sponsor:** Coria Laboratories, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2008-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621218, "A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00621218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*